Comparison

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

 

Click on the organs and learn more about cancer types

´

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

2719 Item(s)

per page

Name PDF Type Clone Specific against Appl. Host Item no. Amount Price
Sotevtamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5878-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Sotevtamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5878-1mg

IchorBio
1 mg Login
Compare
Sotevtamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5878-25mg

IchorBio
25 mg Login
Compare
Sotevtamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5878-50mg

IchorBio
50 mg Login
Compare
Sotevtamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5878-5mg

IchorBio
5 mg Login
Compare
Suciraslimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5884-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Suciraslimab Biosimilar -­ Research Grade Hu FA CHO cells ICH5884-1mg

IchorBio
1 mg Login
Compare
Oregovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5743-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Oregovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5743-1mg

IchorBio
1 mg Login
Compare
Oregovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5743-25mg

IchorBio
25 mg Login
Compare
Oregovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5743-50mg

IchorBio
50 mg Login
Compare
Oregovomab Biosimilar -­ Research Grade Hu FA CHO cells ICH5743-5mg

IchorBio
5 mg Login
Compare
Oregovomab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5743V-0.1mg

IchorBio
0.1 mg Login
Compare
Oregovomab Vedotin Biosimilar -­ Research Grade Hu FA CHO cells ICH5743V-1mg

IchorBio
1 mg Login
Compare
Pacibekitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5751-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Pacibekitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5751-1mg

IchorBio
1 mg Login
Compare
Pacibekitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5751-25mg

IchorBio
25 mg Login
Compare
Pacibekitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5751-50mg

IchorBio
50 mg Login
Compare
Pacibekitug Biosimilar -­ Research Grade Hu FA CHO cells ICH5751-5mg

IchorBio
5 mg Login
Compare
Pelgifatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5766-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Pelgifatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5766-1mg

IchorBio
1 mg Login
Compare
Pelgifatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5766-25mg

IchorBio
25 mg Login
Compare
Pelgifatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5766-50mg

IchorBio
50 mg Login
Compare
Pelgifatamab Biosimilar -­ Research Grade Hu FA CHO cells ICH5766-5mg

IchorBio
5 mg Login
Compare
Pepinemab Biosimilar -­ Research Grade Hu FA CHO cells ICH5768-10mg

IchorBio
10 mg (2 x 5 mg) Login
Compare
Name Price
Sotevtamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Sotevtamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Sotevtamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Sotevtamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Sotevtamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Suciraslimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Suciraslimab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Oregovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Oregovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Oregovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Oregovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Oregovomab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Oregovomab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 0.1 mg
Available
Oregovomab Vedotin Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Pacibekitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Pacibekitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Pacibekitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Pacibekitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Pacibekitug Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Pelgifatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available
Pelgifatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 1 mg
Available
Pelgifatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 25 mg
Available
Pelgifatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 50 mg
Available
Pelgifatamab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 5 mg
Available
Pepinemab Biosimilar -­ Research Grade Login
Type
Clone
Specific against Hu
Appl. FA
Host CHO cells
Item no.
Amount 10 mg (2 x 5 mg)
Available

2719 Item(s)

per page